Scripps Tumorgraft Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01726699

Enrollment

Registered

2012-11-15

Start date

2012-11-30

Completion date

2014-07-31

Last updated

2015-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumor Malignancy or Hematologic Malignancy

Brief summary

Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 21 or over * diagnosis of a solid tumor malignancy, either resectable or metastatic or a hematologic malignancy * cognitively and emotionally able to give informed consent

Exclusion criteria

* Under age 21 * Not cognitively or emotionally able to give informed consent

Design outcomes

Primary

Measure	Time frame
Facilitate the development of individualized tumorgraft models for many different types of cancer.	3 years

Countries

United States

Outcome results